CTOs on the Move

OnMetric

www.onmetric.com

 
OnMetric is a purpose-built tool for the events industry to unify and harness the potential of your customer data and apply advanced ticket science.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Global Network Systems

Global Network Systems is a Exeter, NH-based company in the Software and Internet sector.

Tekskills

Tekskills is a Edison, NJ-based company in the Software and Internet sector.

Dominion Enterprises

Dominion Enterprises is a leading marketing services company serving the wide-ranging needs of many industries including real estate, apartments, automotive, and travel. Dominion Enterprises was established in September 2006 following a division of assets of its predecessor company, Trader Publishing Company, between shared owners Landmark and Cox Communications, Inc. Today, with our classified advertising, publishing, technology, data and Web products and services, Dominion Enterprises is well positioned to maintain its dominant market position and is poised to expand upon our proven record of success through organic growth and strategic acquisitions. With best-of-category magazines and Web sites, Dominion Enterprises is one of the largest providers of highly targeted classified advertising. Our familiar brands are recognized from coast to coast and include ForRent.com, Homes.com, DX1 and Dominion Dealer Solutions.

PCCI

@PCCInnovation leverages data scientists, expert clinicians and social determinants of health to better support under-served populations across our communities.

Perthera

Perthera, Inc. is a service company that helps guide patients and their physicians to the best cancer treatment options available by bridging the gap between molecular testing and patient therapy. We provide a more complete view of the molecular pathways driving advanced stage cancer than any other company. By combining genomics, proteomics and clinical history, Perthera delivers a comprehensive molecular analysis of a patient`s tumor and identifies the best available FDA approved therapies and clinical trials for each individual patient.